Study S002639

A Randomised, Double-Blind, Placebo-Controlled Trial Evaluating the Effects of elénzia CONTROL® on Weight and Metabolic Health in Adults Naïve to or Who Have Recently Discontinued Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use

ClinicalTrials.gov record

Registration

Registration: NCT07789223
Acronym: WMMS
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: TRIPLE
Status: RECRUITING
Enrollment: 200
Start: 2026-09-15
Primary completion: 2027-02
Lead sponsor: Elenzia
Conditions: Overweight; Obesity; Weight Maintenance
Interventions: DIETARY_SUPPLEMENT:elénzia CONTROL®; DIETARY_SUPPLEMENT:Placebo
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Percentage Change in Body Weight From Baseline to Week 16 [Baseline to Week 16]
Absolute Change in Body Weight From Baseline to Week 16 [Baseline to Week 16]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.